Back
Structure Therapeutics Stock Price Chart
Buy these stocks BEFORE President Trump returns to the Oval Office
See details on which stocks are poised to surge.
Sell
18
GPCR
Structure Therapeutics
Last Price:
34.18
Seasonality Move:
-11.15%
7 Day Trial
ALL ACCESS PASS
$
7
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and GPCR is experiencing selling pressure, which indicates risk of future bearish movement.
Structure Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 37.32 | Sell |
| 20-day SMA: | 38.28 | Sell |
| 50-day SMA: | 39.33 | Sell |
| 200-day SMA: | 40.08 | Sell |
| 8-day EMA: | 37.04 | Sell |
| 20-day EMA: | 38.08 | Sell |
| 50-day EMA: | 38.82 | Sell |
| 200-day EMA: | 39.53 | Sell |
Structure Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.81 | Sell |
| Relative Strength Index (14 RSI): | 35.81 | Sell |
| Chaikin Money Flow: | -937317 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (36.72 - 39.7) | Sell |
| Bollinger Bands (100): | (36.27 - 41.27) | Sell |
Structure Therapeutics Technical Analysis
| Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Structure Therapeutics Stock
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 34.17 while GPCR 8-day simple moving average is 37.32, which is a Sell signal.
- The stock price of GPCR is 34.17 while Structure Therapeutics 20-day SMA is 38.28, which makes it a Sell.
- Structure Therapeutics 50-day simple moving average is 39.33 while GPCR share price is 34.17, making it a Sell technically.
- GPCR stock price is 34.17 and Structure Therapeutics 200-day simple moving average is 40.08, creating a Sell signal.
GPCR Technical Analysis vs Fundamental Analysis
Sell
18
Structure Therapeutics (GPCR)
is a Sell
Is Structure Therapeutics a Buy or a Sell?
-
Structure Therapeutics stock is rated a Sell
The current Structure Therapeutics [GPCR] share price is $34.17. The Score for GPCR is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
Structure Therapeutics Stock Info
Market Cap:
1.95B
Price in USD:
34.17
Share Volume:
1.08M
Structure Therapeutics 52-Week Range
52-Week High:
66.38
52-Week Low:
26.61
Sell
18
Structure Therapeutics (GPCR)
is a Sell
Structure Therapeutics Share Price Forecast
-
What is the Structure Therapeutics stock price today?
The Structure Therapeutics stock price is 34.17 USD today. -
Will GPCR stock go up or go down?
Structure Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Structure Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Structure Therapeutics is overvalued.
Is Structure Therapeutics Stock a Buy?
- Structure Therapeutics share price is 34.17 while GPCR 8-day exponential moving average is 37.04, which is a Sell signal.
- The stock price of GPCR is 34.17 while Structure Therapeutics 20-day EMA is 38.08, which makes it a Sell.
- Structure Therapeutics 50-day exponential moving average is 38.82 while GPCR share price is 34.17, making it a Sell technically.
- GPCR stock price is 34.17 and Structure Therapeutics 200-day simple moving average is 39.53, creating a Sell signal.
Fundamental Analysis of Structure Therapeutics
Is Structure Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.10 per share, and an increase next year of $0.15 per share.
Technical Analysis of Structure Therapeutics
Should I short Structure Therapeutics stock?
- GPCR Moving Average Covergence Divergence (MACD) indicator is -0.81, suggesting Structure Therapeutics is a Sell
- Structure Therapeutics Relative Strength Index (RSI) is 35.81, which suggest Structure Therapeutics is oversold
- The Bollinger Bands (25) for Structure Therapeutics is (36.72 - 39.7), which suggest Structure Therapeutics is a Sell
- The Bollinger Bands (100) for Structure Therapeutics is (36.27 - 41.27), which suggest Structure Therapeutics is a Sell
* Structure Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.